Clinical Trial Update: Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating mesenchymal stem cell therapy for bronchopulmonary dysplasia in preterm infants has completed enrollment. The study was sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: COMPLETED